Select Region or Location
Americas
  • Argentina
  • Brazil
  • Canada
  • Mexico
  • United States
  • Other Americas
Europe
  • Austria
  • Belgium
  • Bulgaria
  • Croatia/Hrvatska
  • Cyprus
  • Czech Republic
  • Denmark
  • Estonia
  • Finland
  • France
  • Germany
  • Greece
  • Hungary
  • Ireland
  • Italy
  • Latvia
  • Liechtenstein
  • Lithuania
  • Luxembourg
  • Malta
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Romania
  • Slovak Republic
  • Slovenia
  • Spain
  • Sweden
  • Switzerland
  • Turkey
  • United Kingdom
  • Other Europe
Asia Pacific
  • Australia
  • China
  • India
  • Indonesia
  • Japan
  • Korea, Republic of
  • Malaysia
  • New Zealand
  • Philippines
  • Singapore
  • Thailand
  • Vietnam
  • Other Asia Pacific
Africa And Middle East
  • Egypt
  • Israel
  • Other Africa And Middle East
USD
Home Cart Sign in  
Chemical Structure| 143825-84-7 Chemical Structure| 143825-84-7

Structure of 143825-84-7

Chemical Structure| 143825-84-7

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

4.5 *For Research Use Only! Not for Human Use. We Do Not Sell to Patients.

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

DE Stock

US Stock

Asia Stock

Global Stock

In Stock
{[ item.pr_size ]}{[ size_append_text(item.pr_size, proInfo.prAm, 'list') ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

  • {[ item.pr_size ]}
    {[ size_append_text(item.pr_size, proInfo.prAm, 'list') ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of [ 143825-84-7 ]

CAS No. :143825-84-7
Formula : C14H19BO2
M.W : 230.11
SMILES Code : C=C(B1OC(C)(C)C(C)(C)O1)C2=CC=CC=C2
English Name :4,4,5,5-Tetramethyl-2-(1-phenylvinyl)-1,3,2-dioxaborolane
MDL No. :MFCD06659923
InChI Key :RMGBWPMWUZSIMH-UHFFFAOYSA-N
Pubchem ID :11031671

Safety of [ 143825-84-7 ]

Computational Chemistry of [ 143825-84-7 ] Show Less

Physicochemical Properties

Num. heavy atoms 17
Num. arom. heavy atoms 6
Fraction Csp3 0.43
Num. rotatable bonds 2
Num. H-bond acceptors 2.0
Num. H-bond donors 0.0
Molar Refractivity 72.32
TPSA ?

Topological Polar Surface Area: Calculated from
Ertl P. et al. 2000 J. Med. Chem.

18.46 Ų

Lipophilicity

Log Po/w (iLOGP)?

iLOGP: in-house physics-based method implemented from
Daina A et al. 2014 J. Chem. Inf. Model.

0.0
Log Po/w (XLOGP3)?

XLOGP3: Atomistic and knowledge-based method calculated by
XLOGP program, version 3.2.2, courtesy of CCBG, Shanghai Institute of Organic Chemistry

3.94
Log Po/w (WLOGP)?

WLOGP: Atomistic method implemented from
Wildman SA and Crippen GM. 1999 J. Chem. Inf. Model.

3.33
Log Po/w (MLOGP)?

MLOGP: Topological method implemented from
Moriguchi I. et al. 1992 Chem. Pharm. Bull.
Moriguchi I. et al. 1994 Chem. Pharm. Bull.
Lipinski PA. et al. 2001 Adv. Drug. Deliv. Rev.

2.19
Log Po/w (SILICOS-IT)?

SILICOS-IT: Hybrid fragmental/topological method calculated by
FILTER-IT program, version 1.0.2, courtesy of SILICOS-IT, http://www.silicos-it.com

2.4
Consensus Log Po/w?

Consensus Log Po/w: Average of all five predictions

2.37

Water Solubility

Log S (ESOL):?

ESOL: Topological method implemented from
Delaney JS. 2004 J. Chem. Inf. Model.

-3.88
Solubility 0.0305 mg/ml ; 0.000132 mol/l
Class?

Solubility class: Log S scale
Insoluble < -10 < Poorly < -6 < Moderately < -4 < Soluble < -2 Very < 0 < Highly

Soluble
Log S (Ali)?

Ali: Topological method implemented from
Ali J. et al. 2012 J. Chem. Inf. Model.

-4.03
Solubility 0.0216 mg/ml ; 0.0000939 mol/l
Class?

Solubility class: Log S scale
Insoluble < -10 < Poorly < -6 < Moderately < -4 < Soluble < -2 Very < 0 < Highly

Moderately soluble
Log S (SILICOS-IT)?

SILICOS-IT: Fragmental method calculated by
FILTER-IT program, version 1.0.2, courtesy of SILICOS-IT, http://www.silicos-it.com

-4.45
Solubility 0.00816 mg/ml ; 0.0000355 mol/l
Class?

Solubility class: Log S scale
Insoluble < -10 < Poorly < -6 < Moderately < -4 < Soluble < -2 Very < 0 < Highly

Moderately soluble

Pharmacokinetics

GI absorption?

Gatrointestinal absorption: according to the white of the BOILED-Egg

High
BBB permeant?

BBB permeation: according to the yolk of the BOILED-Egg

Yes
P-gp substrate?

P-glycoprotein substrate: SVM model built on 1033 molecules (training set)
and tested on 415 molecules (test set)
10-fold CV: ACC=0.72 / AUC=0.77
External: ACC=0.88 / AUC=0.94

Yes
CYP1A2 inhibitor?

Cytochrome P450 1A2 inhibitor: SVM model built on 9145 molecules (training set)
and tested on 3000 molecules (test set)
10-fold CV: ACC=0.83 / AUC=0.90
External: ACC=0.84 / AUC=0.91

No
CYP2C19 inhibitor?

Cytochrome P450 2C19 inhibitor: SVM model built on 9272 molecules (training set)
and tested on 3000 molecules (test set)
10-fold CV: ACC=0.80 / AUC=0.86
External: ACC=0.80 / AUC=0.87

No
CYP2C9 inhibitor?

Cytochrome P450 2C9 inhibitor: SVM model built on 5940 molecules (training set)
and tested on 2075 molecules (test set)
10-fold CV: ACC=0.78 / AUC=0.85
External: ACC=0.71 / AUC=0.81

No
CYP2D6 inhibitor?

Cytochrome P450 2D6 inhibitor: SVM model built on 3664 molecules (training set)
and tested on 1068 molecules (test set)
10-fold CV: ACC=0.79 / AUC=0.85
External: ACC=0.81 / AUC=0.87

Yes
CYP3A4 inhibitor?

Cytochrome P450 3A4 inhibitor: SVM model built on 7518 molecules (training set)
and tested on 2579 molecules (test set)
10-fold CV: ACC=0.77 / AUC=0.85
External: ACC=0.78 / AUC=0.86

No
Log Kp (skin permeation)?

Skin permeation: QSPR model implemented from
Potts RO and Guy RH. 1992 Pharm. Res.

-4.91 cm/s

Druglikeness

Lipinski?

Lipinski (Pfizer) filter: implemented from
Lipinski CA. et al. 2001 Adv. Drug Deliv. Rev.
MW ≤ 500
MLOGP ≤ 4.15
N or O ≤ 10
NH or OH ≤ 5

0.0
Ghose?

Ghose filter: implemented from
Ghose AK. et al. 1999 J. Comb. Chem.
160 ≤ MW ≤ 480
-0.4 ≤ WLOGP ≤ 5.6
40 ≤ MR ≤ 130
20 ≤ atoms ≤ 70

None
Veber?

Veber (GSK) filter: implemented from
Veber DF. et al. 2002 J. Med. Chem.
Rotatable bonds ≤ 10
TPSA ≤ 140

0.0
Egan?

Egan (Pharmacia) filter: implemented from
Egan WJ. et al. 2000 J. Med. Chem.
WLOGP ≤ 5.88
TPSA ≤ 131.6

0.0
Muegge?

Muegge (Bayer) filter: implemented from
Muegge I. et al. 2001 J. Med. Chem.
200 ≤ MW ≤ 600
-2 ≤ XLOGP ≤ 5
TPSA ≤ 150
Num. rings ≤ 7
Num. carbon > 4
Num. heteroatoms > 1
Num. rotatable bonds ≤ 15
H-bond acc. ≤ 10
H-bond don. ≤ 5

0.0
Bioavailability Score?

Abbott Bioavailability Score: Probability of F > 10% in rat
implemented from
Martin YC. 2005 J. Med. Chem.

0.55

Medicinal Chemistry

PAINS?

Pan Assay Interference Structures: implemented from
Baell JB. & Holloway GA. 2010 J. Med. Chem.

0.0 alert
Brenk?

Structural Alert: implemented from
Brenk R. et al. 2008 ChemMedChem

1.0 alert: heavy_metal
Leadlikeness?

Leadlikeness: implemented from
Teague SJ. 1999 Angew. Chem. Int. Ed.
250 ≤ MW ≤ 350
XLOGP ≤ 3.5
Num. rotatable bonds ≤ 7

No; 1 violation:MW<2.0
Synthetic accessibility?

Synthetic accessibility score: from 1 (very easy) to 10 (very difficult)
based on 1024 fragmental contributions (FP2) modulated by size and complexity penaties,
trained on 12'782'590 molecules and tested on 40 external molecules (r2 = 0.94)

2.8

Application In Synthesis of [ 143825-84-7 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Downstream synthetic route of [ 143825-84-7 ]

[ 143825-84-7 ] Synthesis Path-Downstream   1~14

  • 1
  • [ 98-81-7 ]
  • [ 73183-34-3 ]
  • [ 143825-84-7 ]
YieldReaction ConditionsOperation in experiment
88% With triphenylphosphine In toluene mixt. in toluene stirred at 50°C for 5 h; treated (H2O) at room temp.; extd. (benzene); washed with brine; dried (MgSO4); purified by chromy. on silica gel or by distn. (vac.);
53.2% With bis-triphenylphosphine-palladium(II) chloride; sodium phenoxide; triphenylphosphine; potassium bromide In toluene at 70℃; for 16h; Inert atmosphere; 1-4 General procedure: Add sodium phenolate PhONa (95.13g) to the mixture of (1-bromovinyl)benzene, which is raw material 1 (100g, 0.548mol) and biborate, which is raw material 2 (153.11g, 0.603mol), and toluene solvent (1L). , 0.82mol), KBr (97.52g, 0.82mol), triphenylphosphine PPh3 (4.31g, 16.44mmol) and dichlorobis(triphenylphosphino)palladium Pd(PPh3)2Cl2 (7.68g, 10.96mmol). Stir for 16 hours under the protection of inert gas at 70°C. TLC (petroleum ether: ethyl acetate = 15:1) showed that the raw material 1 ((1-bromovinyl)benzene) was consumed and new compounds were formed. After the reaction mixture was filtered, the filtrate was concentrated under reduced pressure to remove the solvent. The concentrated solution was diluted with water and extracted with ethyl acetate solvent. The extracted organic layer was washed with brine, dried over Na2SO4, filtered and concentrated under reduced pressure to obtain a crude product. Then dilute the crude product with petroleum ether and ethyl acetate, stir for several hours, filter, collect the filtrate and concentrate to obtain a solid. The solid was recrystallized with petroleum ether at 0°C to obtain the final product, which was a yellow solid (64.28 g, 0.279 mol, yield 51.1%).
88 % Chromat. With potassium phenolate; triphenylphosphine In toluene at 50℃; for 5h;
88 % Chromat. With potassium phenolate; triphenylphosphine In toluene at 50℃; for 5h;
With C6H5OK In toluene mixt. of alkene, B compound, base, Pd catalyst and PPh3 was stirred at 50°C for 5 h; Kugelrohr distn. or chromy. on silica gel; 88% GC yield;
With bis-triphenylphosphine-palladium(II) chloride; potassium phenolate; triphenylphosphine In toluene at 50℃;
With bis-triphenylphosphine-palladium(II) chloride; potassium phenolate; triphenylphosphine In toluene at 50℃; for 5h; Inert atmosphere; 92.1 Step 1. 4.4.5.5-tetramethyl-2-(1-phenylethenyl)-1 ,3.2-dioxaborolane Into a 50-mL round-bottom flask purged and maintained with an inert atmosphere of nitrogen was added (l-bromoethenyl)benzene (800 mg, 4.370 mmol, 1.00 equiv), 4,4,5,5-tetramethyl-2-(tetramethyl-1 ,3,2-dioxaborolan-2-yl)- 1 ,3,2-dioxaborolane (1.23 g, 4.840 mmol, 1.11 equiv), potassium phenolate (870 mg, 6.580 mmol, 1.51 equiv), Pd(PPh3)2Cl2 (92 mg, 0.080 mmol, 0.02 equiv), PPhi3 (69 mg, 0.260 mmol, 0.06 equiv) and toluene (15 ml_). The resulting mixture was stirred for 5 h at 50 °C in an oil bath and then concentrated under vacuum. The residue was dissolved in ethyl acetate and washed with water (10 ml_) and concentrated under vacuum. The residue was applied onto a silica gel column with ethyl acetate/petroleum ether (5:95) to yield 4,4,5,5-tetramethyl-2-(1-phenylethenyl)-1 ,3,2-dioxaborolane as brown oil.

  • 2
  • [ 28143-79-5 ]
  • [ 73183-34-3 ]
  • [ 143825-84-7 ]
YieldReaction ConditionsOperation in experiment
99% With triphenylphosphine In toluene mixt. in toluene stirred at 50°C for 4 h; treated (H2O) at room temp.; extd. (benzene); washed with brine; dried (MgSO4); purified by chromy. on silica gel or by distn. (vac.);
99 % Chromat. With potassium phenolate; triphenylphosphine In toluene at 50℃; for 4h;
  • 3
  • [ CAS Unavailable ]
  • [ 25015-63-8 ]
  • [ 83947-56-2 ]
  • [ 143825-84-7 ]
YieldReaction ConditionsOperation in experiment
With triethylamine In tetrahydrofuran at 25℃; for 14h; Title compound not separated from byproducts.;
With Ru(at)TBAB at 85℃; for 23h; Inert atmosphere; stereoselective reaction; 2.3. General procedure for phenylacetylene hydroboration Pinacolborane (1.0 mmol) and then phenylacetylene (1.0 mmol)were added under argon to the M(at)OS (0.1 mol%) contained in a15 mL reaction tube. The mixture was stirred at 85°C for 23 h.The reaction mixture was then diluted in dichloromethane andfiltrated over a pad of silica. After washing twice with 10 mLof dichloromethane the filtrate was concentrated under vacuumto give the corresponding vinylborane as a mixture of isomers.Product distribution was determined by GC/MS. Conversion isdetermined using the relative areas in GC/MS and according tomesitylene as internal standard. The spectral data were in agree-ment with those reported in the literature.
With [Rh(CO)(2-pyridyldiphenylphosphine)(2-iodo-3,4,5,6-tetrafluorophenyldiphenylphosphine)]BARF In dichloromethane-d2 at 20℃; for 24h; Inert atmosphere; Overall yield = 88 %Spectr.;
With PhboxmiCo(CH2SiMe3) In hexane; toluene at 20℃; for 15h; Overall yield = 64 percent; regioselective reaction;
28 %Chromat. With C78H66N10(4+)*4F6P(1-); cobalt(II) chloride; sodium t-butanolate In tetrahydrofuran at 20℃; for 16h; Inert atmosphere; Schlenk technique; Glovebox;
1: 78 %Chromat. 2: 8 %Chromat. With potassium <i>tert</i>-butylate In dimethyl sulfoxide at 25℃; Inert atmosphere; Glovebox; Schlenk technique;

  • 4
  • [ 143825-84-7 ]
  • [ 257298-92-3 ]
  • [ 257298-93-4 ]
YieldReaction ConditionsOperation in experiment
With C32H12BF24(1-)*C33H43IrN2OP(1+); hydrogen In dichloromethane at 20℃; for 18h; optical yield given as %ee; enantioselective reaction;
With C32H12BF24(1-)*C35H38IrN2PS(1+); hydrogen In dichloromethane at 20℃; for 18h; optical yield given as %ee; enantioselective reaction;
Multi-step reaction with 2 steps 1: Rh/C; hydrogen / toluene / 4 h / 20 °C 2: phosphite dehydrogenase; recombinant phenylacetone monooxygenase from Thermobifida fusca; NADPH / dimethyl sulfoxide / 5 h / 30 °C / pH 7.5 / Tris/HCl buffer; Enzymatic reaction
Multi-step reaction with 2 steps 1: Rh/C; hydrogen / toluene / 4 h / 20 °C 2: phosphite dehydrogenase; recombinant phenylacetone monooxygenase from Thermobifida fusca; NADPH / dimethyl sulfoxide / 3 h / 30 °C / pH 9 / Tris/HCl buffer; Enzymatic reaction
With C32H12BF24(1-)*C36H57IrN2OP(1+); hydrogen In dichloromethane at -20℃; for 4h; Autoclave; optical yield given as %ee; enantioselective reaction;
Multi-step reaction with 2 steps 1: Rh/C; hydrogen / toluene 2: phosphite dehydrogenase; phosphite; recombinant Thermobifida fusca phenylacetone monooxygenase M446G mutant; oxygen; NADPH / dimethyl sulfoxide / 4 h / 30 °C / pH 7.5 / aq. buffer; Enzymatic reaction
Multi-step reaction with 2 steps 1: Rh/C; hydrogen / toluene 2: phosphite dehydrogenase; phosphite; recombinant Thermobifida fusca phenylacetone monooxygenase; oxygen; NADPH / dimethyl sulfoxide / 5 h / 30 °C / pH 7.5 / aq. buffer; Enzymatic reaction
88 % ee With C49H45IrN2O3P(1+)*C32H12BF24(1-); hydrogen In dichloromethane at 20℃; for 4h;
74 % ee With C50H59IrO4PS(1+)*C32H12BF24(1-); hydrogen In dichloromethane for 4h; Autoclave; enantioselective reaction;
82 % ee With C42H63IrO3PS(1+)*C32H12BF24(1-); hydrogen In dichloromethane Autoclave; High pressure;
58 % ee With C34H41IrOPS(1+)*C32H12BF24; hydrogen In dichloromethane Autoclave; High pressure;
86 % ee With C47H56IrNO4PSi2(1+)*C32H12BF24(1-); hydrogen In dichloromethane at 20℃; for 4h; Autoclave; enantioselective reaction;
25 % ee With C49H52IrNO4PSi2(1+)*C32H12BF24(1-); hydrogen In dichloromethane at 20℃; for 4h; Autoclave; enantioselective reaction;
60 % ee With [Ir(COD)2]BArF; C39H50NO7PSi2; hydrogen In dichloromethane at 20℃; for 4h; Schlenk technique; Autoclave; enantioselective reaction;
49 % ee With bis(norbornadiene)rhodium(l)tetrafluoroborate; ZhaoPhos; hydrogen In dichloromethane at 30℃; for 6h; Autoclave; Overall yield = 76 %; Overall yield = 17.6 mg; enantioselective reaction;
44 % ee With C32H12BF24(1-)*C43H59IrO3PS(1+); hydrogen In dichloromethane at 20℃; for 16h; Autoclave; Schlenk technique;
74 % ee With C32H12BF24(1-)*C31H37IrOPS(1+); hydrogen In dichloromethane at 20℃; for 16h; Autoclave; Schlenk technique;
80 % ee With C23H43IrN2OP(1+)*C32H12BF24(1-); hydrogen In dichloromethane at 23℃; enantioselective reaction;

References: [1]Location in patent: experimental part Paptchikhine, Alexander; Cheruku, Pradeep; Engman, Mattias; Andersson, Pher G. [Chemical Communications, 2009, # 40, p. 5996 - 5998].
[2]Location in patent: experimental part Paptchikhine, Alexander; Cheruku, Pradeep; Engman, Mattias; Andersson, Pher G. [Chemical Communications, 2009, # 40, p. 5996 - 5998].
[3]Brondani, Patricia B.; De Gonzalo, Gonzalo; Fraaije, Marco W.; Andrade, Leandro H. [Advanced Synthesis and Catalysis, 2011, vol. 353, # 11-12, p. 2169 - 2173].
[4]Brondani, Patricia B.; De Gonzalo, Gonzalo; Fraaije, Marco W.; Andrade, Leandro H. [Advanced Synthesis and Catalysis, 2011, vol. 353, # 11-12, p. 2169 - 2173].
[5]Ganic, Adnan; Pfaltz, Andreas [Chemistry - A European Journal, 2012, vol. 18, # 22, p. 6724 - 6728].
[6]Brondani, Patricia B.; Dudek, Hanna; Reis, Joel S.; Fraaije, Marco W.; Andrade, Leandro H. [Tetrahedron Asymmetry, 2012, vol. 23, # 9, p. 703 - 708].
[7]Brondani, Patricia B.; Dudek, Hanna; Reis, Joel S.; Fraaije, Marco W.; Andrade, Leandro H. [Tetrahedron Asymmetry, 2012, vol. 23, # 9, p. 703 - 708].
[8]Biosca, Maria; Paptchikhine, Alexander; Pÿmies, Oscar; Andersson, Pher G.; Diéguez, Montserrat [Chemistry - A European Journal, 2015, vol. 21, # 8, p. 3455 - 3464].
[9]Margalef, Jèssica; Caldentey, Xisco; Karlsson, Erik A.; Coll, Mercè; Mazuela, Javier; Pàmies, Oscar; Diéguez, Montserrat; Pericàs, Miquel A. [Chemistry - A European Journal, 2014, vol. 20, # 38, p. 12201 - 12214].
[10]Borràs, Carlota; Biosca, Maria; Pàmies, Oscar; Diéguez, Montserrat [Organometallics, 2015, vol. 34, # 21, p. 5321 - 5334].
[11]Borràs, Carlota; Biosca, Maria; Pàmies, Oscar; Diéguez, Montserrat [Organometallics, 2015, vol. 34, # 21, p. 5321 - 5334].
[12]Biosca, Maria; Magre, Marc; Coll, Mercè; Pàmies, Oscar; Diéguez, Montserrat [Advanced Synthesis and Catalysis, 2017, vol. 359, # 16, p. 2801 - 2814].
[13]Biosca, Maria; Magre, Marc; Coll, Mercè; Pàmies, Oscar; Diéguez, Montserrat [Advanced Synthesis and Catalysis, 2017, vol. 359, # 16, p. 2801 - 2814].
[14]Elías-Rodríguez, Pilar; Borràs, Carlota; Carmona, Ana T.; Faiges, Jorge; Robina, Inmaculada; Pàmies, Oscar; Diéguez, Montserrat [ChemCatChem, 2018, vol. 10, # 23, p. 5414 - 5424].
[15]Liu, Gang; Li, Anqi; Qin, Xueyuan; Han, Zhengyu; Dong, Xiu-Qin; Zhang, Xumu [Advanced Synthesis and Catalysis, 2019, vol. 361, # 12, p. 2844 - 2848].
[16]Cruz-Sánchez, Pol De La; Faiges, Jorge; Mazloomi, Zahra; Borràs, Carlota; Biosca, Maria; Pàmies, Oscar; Diéguez, Montserrat [Organometallics, 2019, vol. 38, # 21, p. 4193 - 4205].
[17]Cruz-Sánchez, Pol De La; Faiges, Jorge; Mazloomi, Zahra; Borràs, Carlota; Biosca, Maria; Pàmies, Oscar; Diéguez, Montserrat [Organometallics, 2019, vol. 38, # 21, p. 4193 - 4205].
[18]Biosca, Maria; de la Cruz-Sánchez, Pol; Faiges, Jorge; Margalef, Jèssica; Salomó, Ernest; Riera, Antoni; Verdaguer, Xavier; Ferré, Joan; Maseras, Feliu; Besora, Maria; Pàmies, Oscar; Diéguez, Montserrat [ACS Catalysis, 2023, vol. 13, # 5, p. 3020 - 3035].
  • 5
  • [ 1233335-28-8 ]
  • [ 143825-84-7 ]
  • [ 1233376-46-9 ]
YieldReaction ConditionsOperation in experiment
58% With potassium carbonate In 1,4-dioxane at 100℃; for 3h; Inert atmosphere; 81 Example 81 (4R,6R,7S)-4,7-dfftert-butyldimethylsilyloxy)-2-(1-phenylvinyl)-4,5,6,7-tetrahydrobenzo[b]thiophen-4,6-carbolactone (7). A Shlenck tube was charged with iodide VII of example 37 (190 mg, 0.34 mmol), Pd(PPh3)4 (40 mg, 0.03 mmol) and dry dioxane (3.4 mL). Anhydrous K2CO3 (0.92 mL, 1.01 mmol, 1.1 M) and 1-phenylvinylboronic acid pinacol ester (116 mg, 0.50 mmol) was then added and the resultant solution was deoxygenated and heated at 100° C. for 3 h. After cooling to room temperature, the reaction mixture was filtered through a plug of Celite and the precipitate was washed with hexane. The filtrate and the washings were concentrated and the obtained residue was purified by columm chromatography, previously neutralized with 5% triethylamine-hexanes, eluting with diethyl ether-hexanes (5:95) to yield thiophene 7 (105 mg, 58%) as a light yellow oil. [α]D20=-46.6° (c1.9, in CHCl3). 1H NMR (250 MHz, CDCl3) δ 6.88-6.85 (m, 5H, 5*ArH), 6.86 (s, 1H, H-2), 5.56 (s, 1H), 5.26 (s, 1H), 4.86 (d, J=3.2 Hz, 1H, H-7), 4.67 (dd, J=5.6 and 3.2 Hz, 1H, H-6), 2.61 (d, J=10.9 Hz, 1H, H-5ax), 2.51 (dd, J=10.9 and 5.8 Hz, 1H, H-5eq), 0.94 (s, 9H, C(CH3)3), 0.89 (s, 9H, C(CH3)3), 0.23 (s, 3H, CH3), 0.21 (s, 3H, CH3), 0.20 (s, 3H, CH3) and 0.11 (s, 3H, CH,) ppm. 13C NMR (63 MHz, CDCl3) δ 175.1 (C), 145.3 (C), 143.1 (C), 141.7 (C), 140.2 (C), 134.0 (C), 128.2 (2*CH), 128.1 (3*CH), 122.4 (CH), 114.0 (CH2), 77.2 (CH), 75.3 (C), 66.3 (CH), 37.8 (CH2), 25.7 (C(CH3)3), 25.5 (C(CH3)3), 18.1 (C(CH3)3), 18.0 (C(CH3)3), -3.0 (CH3), -3.2 (CH3), -4.6 (CH3) and -4.6 (CH3) ppm. IR (film) 1803 (C=O) cm-. MS (ESI) m/z (%) 543 (MH+). HRMS calcd for C29H43O4SSi2 (MH+): 543.2415; found, 543.2412.
  • 6
  • [ 75-11-6 ]
  • [ 143825-84-7 ]
  • [ 1314495-37-8 ]
YieldReaction ConditionsOperation in experiment
75% With diethylzinc In dichloromethane
92 % Stage #1: diiodomethane With diethylzinc In dichloromethane; toluene at 0℃; Inert atmosphere; Stage #2: 4,4,5,5-tetramethyl-2-(1-phenylvinyl)-1,3,2-dioxaborolane In dichloromethane; toluene at 0℃; Inert atmosphere; 17.1 17.1 Synthesis of compound L017-1 At room temperature, diiodomethane (5.9g, 21.72mmol) was added to dichloromethane (40mL), cooled to 0°C, and after stirring for 5 minutes under a nitrogen atmosphere, a toluene solution of diethylzinc (10.8mL, 10.8mmol, 1M toluene solution), the reaction solution was stirred at 0°C for 0.5 hours.Then, a solution of L017-a (1 g, 4.35 mmol) in dichloromethane (10 mL) was slowly added dropwise, and the reaction solution was continued to stir at 0°C for 0.5 hours, and then the temperature was raised to room temperature and stirred for 16 hours.Add saturated aqueous ammonium chloride solution (50 mL) to the reaction solution to quench, and stir for 3 to 5 minutes.Extract with dichloromethane (50 mL×3), wash the combined organic phases with saturated brine (50 mL), dry over anhydrous sodium sulfate, filter, and concentrate the filtrate under reduced pressure.The residue was purified by silica gel column chromatography to obtain compound L017-1 (979 mg, yield 92%).
  • 7
  • [ 143825-84-7 ]
  • [ 55826-72-7 ]
  • [ 1425511-87-0 ]
YieldReaction ConditionsOperation in experiment
91% With caesium carbonate In 1,4-dioxane; water at 80℃; for 6h; Inert atmosphere; Intermediate 25; 3,4-bis(BenzyIoxy)-6-(l-phenylethenyl)pyridazine General procedure: Intermediate 25; 3,4-bis(BenzyIoxy)-6-(l-phenylethenyl)pyridazine A mixture of 3,4-bis(benzyloxy)-6-chloropyridazine (Intermediate 1: 3 g. 9.18 mmol), dioxane (32.1 ml) and water (9.64 ml) was degassed and to this was added mono(bis(di- tert-butyl(4-(dimethylamino)phenyl)phosphonio)palladium(IV)) dichloride (0.195 g, 0.275 mmol), cesium carbonate (10.14 g, 31.1 mmol) and 4,4,5>5-tetramefhyl-2-(l- phenylethenyl)-l,3,2-dioxaborolane (3 g, 13.04 mmol). The mixture was heated to 80 °C for 6 hours and upon cooling was partitioned between dichloromethane and water.The organic portion was dried (MgS ), filtered and concentrated to give an orange oil. The crude oil was purified by silica chromatography eluting with 0-60 % ethyl acetate in petrol to afford 3,4-bis(benzyloxy)-6-(l-phenylethenyl)pyridazine as a brown oil (yield = 91 %). Ή NMR (400 MHz, CHCl3-d) δ 7.54 - 7.66 (m, 2 H), 7.24 - 7.44 (m, 13 H), 6.72 (s, 1H), 6.02 (s, 1H), 5.70 (s, 2H), 5.63 (s, 1H), 5. 1 (s, 2H). MS ES+: 395.
91% With bis(di-tert-​butyl(4-​dimethylaminophenyl)​phosphine)​dichloropalladium(II); caesium carbonate In 1,4-dioxane; water at 80℃; for 6h; Intermediate 25: 3,4-bis(Benzyloxy)-6-(1-phenylethenyl)pyridazine Intermediate 25: 3,4-bis(Benzyloxy)-6-(1-phenylethenyl)pyridazine[0310][0311]A mixture of 3,4-bis(benzyloxy)-6-chloropyridazine (Intermediate 1: 3 g, 9.18 mmol), dioxane (32.1 ml) and water (9.64 ml) was degassed and to this was added mono(bis(di-tert-butyl(4-(dimethylamino)phenyl)phosphonio)palladium(IV))dichloride (0.195 g, 0.275 mmol), cesium carbonate (10.14 g, 31.1 mmol) and 4,4,5,5-tetramethyl-2-(1-phenylethenyl)-1,3,2-dioxaborolane (3 g, 13.04 mmol). The mixture was heated to 80° C. for 6 hours and upon cooling was partitioned between dichloromethane and water. The organic portion was dried (MgSO4), filtered and concentrated to give an orange oil. The crude oil was purified by silica chromatography eluting with 0-60% ethyl acetate in petrol to afford 3,4-bis(benzyloxy)-6-(1-phenylethenyl)pyridazine as a brown oil (yield=91%).[0312]1H NMR (400 MHz, CHCl3-d) δ 7.54-7.66 (m, 2H), 7.24-7.44 (m, 13H), 6.72 (s, 1H), 6.02 (s, 1H), 5.70 (s, 2H), 5.63 (s, 1H), 5.11 (s, 2H).[0313]MS ES+: 395.
  • 8
  • [ 445003-37-2 ]
  • [ 143825-84-7 ]
  • [ 1438383-20-0 ]
YieldReaction ConditionsOperation in experiment
91% With tetrakis(triphenylphosphine) palladium(0); sodium carbonate In 1,4-dioxane; water at 90℃; for 18h; Inert atmosphere; 78.2; 88.2 Tert-butyl 2-methyl-4-(l-phenylvinyl)benzoate. Tert-butyl 2-methyl-4-(l-phenylvinyl)benzoate. To a solution of tert-butyl 4- bromo-2-methylbenzoate (2 g, 7 mmol) in dioxane/water (50 mL, 4: 1) was added styrylboronic acid pinacol ester (1.64 g, 7 mmol), tetrakis(triphenylphosphine)palladium (0.7 mmol, 0.904 g), sodium carbonate (21 mmol, 2.3 g). The mixture was stirred at 90 °C under nitrogen gas atmosphere for 18 hours. LC-MS showed the start material has been consumed. Then evaporated the solvent and purified by column chromatography (silica gel, petroleum ether/ethyl acetate = 30: 1) to give tert-butyl 2-methyl-4-(l-phenylvinyl)benzoate (1.8 g, 91%). 1H-NMR (300 MHz, CD3OD) δ 7.80 (d, J = 8.1 Hz, 1H), 7.32-7.19 (m, 5H), 7.18 (s, 2H), 5.49 (t, J = 3.3 Hz, 2H), 2.56 (s, 3H), 1.60 (s, 9H).
  • 9
  • [ 25015-63-8 ]
  • [ 143825-84-7 ]
  • [ 428819-24-3 ]
YieldReaction ConditionsOperation in experiment
89% With tetrabutylammonium acetate In neat (no solvent) at 90℃; for 20h; Inert atmosphere; Schlenk technique;
81% With copper(I) thiophene-2-carboxylate; Xantphos; sodium t-butanolate In toluene at 20℃; for 24h; regioselective reaction;
  • 10
  • [ 189105-78-0 ]
  • [ 143825-84-7 ]
  • [ 1957216-58-8 ]
YieldReaction ConditionsOperation in experiment
77% With bis(tri-t-butylphosphine)palladium(0); diisopropylamine In toluene at 80℃; for 24h; Inert atmosphere; Compound 6a General procedure: 1,8-Diiodoanthracene (4, 3.00 g, 6.98mmol) was dissolved in a mixture of degassed toluene (70 mL)and diisopropylamine (3.92 mL, 27.9mmol). To the solution were added 5a (3.58 mL, 20.9mmol) and [Pd(PtBu3)2] (357 mg, 0.699mmol). The reaction mixture was heated at 80 °C for 24 h under Ar. After the mixture was filtered through Celite, the filtrate was evaporated. The crude product was purified by chromatography on silica gel with toluene/CH2Cl2 1:1 eluent to give the desired compound as black oil. Yield 2.89 g (86%)
  • 12
  • [ 66003-76-7 ]
  • [ 143825-84-7 ]
  • [ 221006-75-3 ]
YieldReaction ConditionsOperation in experiment
57% With water; potassium carbonate In dichloromethane at 100℃; for 12h; Sealed tube; Inert atmosphere; 2.5 Example 5 Preparation of 1-phenyl-2-phenylethyleneboronic acid pinacol ester Weighed diphenyl iodonium triflate (0.5 mmol, 215 mg), potassium carbonate (0.5 mmol, 69 mg)In a 25 mL sealed tube, a magnetic charge was added, and after replacing the air in the sealed tube three times with high-purity nitrogen, 1-phenyl-1-vinylboronic acid pinacol ester (1 mmol, 230 mg) was added to the sealed tube under nitrogen protection. 2.5 mL of dichloromethane, deionized water (20 mmol, 333 μl)The tube was tightly sealed, transferred to an oil bath at 100 ° C and stirred for 12 h. TLC detection and tracking reaction, after the reaction is over, willThe tube was cooled to room temperature. Add 5 mL of distilled water to the system to quench the reaction, stir; extract 3 times with 5 mL of dichloromethane, and combineThe machine phase was dried over magnesium sulfate, and the solvent was removed by a rotary evaporator to obtain a crude product; the crude product was loaded on silica gel, eluentAfter purification by column chromatography using a volume ratio of petroleum ether: ethyl acetate = 50:1The pure 1-phenyl-2-phenylethylene boronic acid pinacol ester was obtained as a white solid, and the isolated yield was 57%.
  • 13
  • [ 59786-31-1 ]
  • [ 143825-84-7 ]
  • [ 2355270-49-2 ]
YieldReaction ConditionsOperation in experiment
50% With potassium phosphate; palladium diacetate; tricyclohexylphosphine In toluene at 100℃; 72 Synthesis of (S)-N-(2-(2-cyano-4,4-difluoropyrrolidin-1-yl)-2-oxoethyl)-3-(1-phenylvinyl)isonicotinamide Example 72 Synthesis of (S)-N-(2-(2-cyano-4,4-difluoropyrrolidin-1-yl)-2-oxoethyl)-3-(1-phenylvinyl)isonicotinamide Compound 122a. To a solution of methyl 3-bromoisonicotinate (1.0 g, 4.6 mmol, 1.0 equiv) in toluene (10 mL) was added 4,4,5,5-tetramethyl-2-(1-phenylvinyl)-1,3,2-dioxaborolane (1.06 g, 4.6 mmol, 1.0 equiv), K3O4P (1.96 g, 9.2 mmol, 2.0 equiv) followed by the addition of Palladium(II) acetate (0.104 g, 0.46 mmol. 0.1 equiv), and Tricyclohexylphosphine (0.130 g, 0.46 mmol. 0.1 equiv) The resulting reaction mixture was heated at 100° C. for overnight. Product formation was confirmed by LCMS. After completion of reaction, the mixture was diluted with water (200 mL) and extracted with ethyl acetate (150 mL*2). Combined organic extracts were washed with water (20 mL*2), dried over anhydrous Na2SO4 and concentrated. The crude product obtained was purified by flash chromatography (0-20% ethyl acetate in hexane as an eluent) to obtain methyl 3-(1-phenylvinyl)isonicotinate (0.560 g, 50% Yield) as brown semi solid.
  • 14
  • [ CAS Unavailable ]
  • [ 25015-63-8 ]
  • [ 143825-84-7 ]
YieldReaction ConditionsOperation in experiment
96% With [Cu(OH)(IPr)] In neat (no solvent) at 20℃; for 24h; Inert atmosphere; Schlenk technique; Glovebox;
86% With C48H108Cl2Co2N8P6U2 In tetrahydrofuran at 20℃; for 24h; Inert atmosphere; Sealed tube; regioselective reaction; General procedures for the hydroboration of alkynes catalyzed by complex 3 General procedure: In an argon-filled glove box, to a 10 mL vial equipped with a stir bar, the alkyne (0.1 mmol)and HBpin (16.0 μL, 0.11 mmol, 1.1 equiv) were added followed by complex 3 (4.2 mg,0.0025 mmol, 2.5 mol%). Then anhydrous THF (1.5 mL) was added. The vial was sealedwith a rubber septum, removed from the glove box and the reaction was stirred for 24 h atroom temperature. Additional water was added into the reaction mixture, and the mixturewas extracted with EtOAc. The organic layer was concentrated to give the crude product.CH2Br2 (3.5 μL) was added as an internal standard for NMR analysis. The product waspurified by chromatography on silica gel for each substrate.
86% With C48H108Cl2Co2N8P6U2 In tetrahydrofuran at 20℃; for 24h; Inert atmosphere; Sealed tube; regioselective reaction; General procedures for the hydroboration of alkynes catalyzed by complex 3 General procedure: In an argon-filled glove box, to a 10 mL vial equipped with a stir bar, the alkyne (0.1 mmol)and HBpin (16.0 μL, 0.11 mmol, 1.1 equiv) were added followed by complex 3 (4.2 mg,0.0025 mmol, 2.5 mol%). Then anhydrous THF (1.5 mL) was added. The vial was sealedwith a rubber septum, removed from the glove box and the reaction was stirred for 24 h atroom temperature. Additional water was added into the reaction mixture, and the mixturewas extracted with EtOAc. The organic layer was concentrated to give the crude product.CH2Br2 (3.5 μL) was added as an internal standard for NMR analysis. The product waspurified by chromatography on silica gel for each substrate. 4,4,5,5-Tetramethyl-2-(1-phenylvinyl)-1,3,2-dioxaborolane (7a) Prepared according to the general procedure using 4.2 mg (0.0025 mmol)of complex 3, 16.0 μL (0.882 g/mL, 0.11 mmol) of HBpin, 11.0 μL (0.93 g/mL,0.1 mmol) of phenylacetylene (6a) and 1.5 mL of THF. The crude mixturewas purified by flash column chromatography (PE/EtOAc 50/1 as the eluent)to give 7a (18.5 mg, 86% yield) as a yellow oil. 1H NMR (CDCl3, 500 MHz): δ 7.52-7.50 (m,2H), 7.36-7.33 (m, 2H), 7.28-7.25 (m, 1H), 6.11-6.08 (m, 2H), 1,35 (s, 12H); 11B{1H} NMR(CDCl3, 160 MHz): δ 30.7(s); 13C{1H} NMR (CDCl3, 127 MHz): δ 141.4, 130.9, 128.2, 127.2,127.0, 83.8, 24.8 (Carbon attached to boron not observed due to quadrupolar relaxation).The NMR spectra were consistent with the spectra reported in the literature.4
72% With potassium acetate; C27H25BrCoF3N3O2 In di-isopropyl ether at 40℃; for 36h; Inert atmosphere; Glovebox; Sealed tube;
60% Stage #1: phenylacetylene With Ni(tmhd)2; (1,2-dimethoxyethane)dichloronickel(II); 4'-([1,1'-biphenyl]-4-yl)-2,2':6',2''-terpyridine In tetrahydrofuran at 20℃; for 0.0166667h; Inert atmosphere; Glovebox; Stage #2: pinacolborane In tetrahydrofuran at 60℃; for 2h; Inert atmosphere; Sealed tube; 3 Example 3: Synthesis of 4,4,5,5-tetramethyl-2-(1-phenylvinyl)-1,3,2-dioxaborolane In a glass vial 4 mL under nitrogen gas, Ni(dpm)2 (8.5 mg, 5.0 mol%)), 4'-([1,'1-biphenyl]-4-yl)-2,2':6',2''-terpyridine (L1, 14 mg, 9.0 mol%), NiCl2dme (0.9 mg, 1.0 mol%), anhydrous THF (2.0 mL, 0.20 M), and phenylacetylene, (60 mg, 0.60 mmol, 1.5 equiv) was added, and the reaction mixture was stirred at room temperature for 1 min. Then, HBpin (59 μL, 0.40 mmol, 1.0 equiv) was added to the vial. After sealing, the vial was taken out of the glove box and stirred at 60 °C for 2 h. The mixture was purified by flash column chromatography on silica (hexane:EtOAc = 50:1) to give the title compound as a pale yellow oil (55 mg, 60%).

 

Historical Records

Technical Information

Categories